SCHEMBL7406992

SCHEMBL7406992

COC(=O)C(CNC(=O)c1cc(OCCCNC(=O)OC(C)(C)C)no1)NC(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.49
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
RECQL P46063 1/20 0.46
KLK7 P49862 2/20 0.45
KLK5 Q9Y337 2/20 0.45
PAX8 Q06710 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
KYNU Q16719 1/20 0.41
SUCNR1 Q9BXA5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400723 0.94 SYK (0.50) SYKMAPTPOLBMAPK1L3MBTL1
SCHEMBL13059980 0.83 ITGB3 (0.54) ITGB3ITGA2BKYNU
SCHEMBL7491451 0.80 ITGB3 (0.52) SYKMAPTPOLBMAPK1L3MBTL1
SCHEMBL14496968 0.79 SYK (0.71) SYKKLK5KYNU
SCHEMBL479093 0.79 SYK (0.71) SYKKLK5KYNU
SCHEMBL479092 0.79 SYK (0.71) SYKKLK5KYNU
Hydrochloric Acid SCHEMBL8643329 0.79 ITGB3 (0.51) ITGB3ITGA2BSMPD1
Hydrochloric Acid SCHEMBL8643309 0.79 ITGB3 (0.51) ITGB3ITGA2BSMPD1
SCHEMBL7400722 0.79 SYK (0.47) SYKMAPTPOLBMAPK1L3MBTL1
SCHEMBL6111432 0.78 ITGB3 (0.46) ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828737-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-18 EP disclosed
WO-1996037492-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-28 WO disclosed